Briacell Therapeutics Corp (BCT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 27 | 27 | 27 | 27 | 27 |
| Accounts receivable | 888 | 1 | 10 | -14 | 737 |
| Accounts payable and accrued liabilities | -1,155 | 4 | -1,724 | 769 | -2,937 |
| Other Working Capital | 228 | 406 | -1,076 | 870 | -2,108 |
| Other Operating Activity | -7,692 | -8,571 | -4,399 | -7,573 | -2,674 |
| Operating Cash Flow | $-7,705 | $-8,132 | $-7,163 | $-5,920 | $-6,955 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | -75 | -75 | -105 | -75 | -75 |
| Other Investing Activity | 0 | -7,316 | 0 | 0 | 0 |
| Investing Cash Flow | $-75 | $-7,391 | $-105 | $-75 | $-75 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 13,557 | 14,714 | 4,689 | 11,667 |
| Other Financing Activity | 0 | 0 | 0 | 528 | 293 |
| Financing Cash Flow | $0 | $13,557 | $14,714 | $5,217 | $11,960 |
| Beginning Cash Position | 10,494 | 12,460 | 5,014 | 5,792 | 862 |
| End Cash Position | 2,714 | 10,494 | 12,460 | 5,014 | 5,792 |
| Net Cash Flow | $-7,780 | $-1,966 | $7,447 | $-779 | $4,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,705 | -8,132 | -7,163 | -5,920 | -6,955 |
| Free Cash Flow | -7,705 | -8,132 | -7,163 | -5,920 | -6,955 |